Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced updates on its kidney disease pipeline, which includes treatments for IgA nephropathy (IgAN), primary membranous nephropathy (pMN), and APOL1-mediated kidney disease (AMKD). These updates…
Losing your sight can profoundly impact your life, affecting everything from connections to experiences. Our eyes serve as a window to the world, and when vision is lost, it can…
Walgreens understands that health needs can arise anytime, and sometimes it’s more convenient to have essentials brought directly to you. As a pharmacy-first company, Walgreens has been offering prescription delivery…
The World Health Organization (WHO) held the first meeting of the Acute Care Action Network (ACAN) on October 17–18 in Geneva, Switzerland, bringing together key stakeholders to strengthen global acute…
Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company specializing in targeted therapies for RAS-driven cancers, has announced promising early data on RMC-9805, a selective inhibitor for the RAS(ON) G12D…
D.A. Davidson has announced its role as the exclusive sell-side financial advisor to Allivet, Inc., an online pet pharmacy specializing in medications, supplements, and various pet products, regarding its upcoming…
GenSight Biologics Reports €3.4 Million Cash Position as of September 30, 2024, and Business Update GenSight Biologics (“GenSight” or the “Company”) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharmaceutical company…
Launch of Access to Health Initiative Announced at World Stroke Congress The World Stroke Organization (WSO) President, Dr. Sheila Martins, officially launched the Access to Health initiative at the annual…
This study investigates the rise of AI-based drug repurposing and assesses the factors that drive or hinder its adoption. Traditional drug discovery methods have limitations that fuel interest in AI-based…
eyonis™ LCS Achieves Key Milestones in REALITY Study; Upcoming Webcast Scheduled Key Highlights: Operational and Financial Overview:Median Technologies (FR0011049824, ALMDT, PEA/SME eligible) announced that its Board of Directors approved the…
GeneDx’s GUARDIAN Study Reveals Promise of Whole Genome Sequencing for Newborns Recent findings published in the Journal of the American Medical Association (JAMA) underscore the limitations of traditional newborn screening…
Havah Therapeutics, a clinical-stage biopharmaceutical company focused on innovative hormonal implant therapies for breast cancer prevention and treatment, has established a Clinical Advisory Board chaired by founder Stephen Birrell, MD,…